Professional Documents
Culture Documents
___________________________________
___________________________________
___________________________________
CANCERUL CERVICAL
Conf. Dr. Nicolae N. Suciu
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Romania al II-lea dupa cancerul de san
Factori de risc:
nivel socio-economic scazut
varsta 45-55 ani
femei cu mai multi parteneri sexuali
prostitutia
relatii sexuale precoce
infectii cu HPV sau HSV2
rasa neagra are o incidenta crescuta
fumat
NU este intalnita la virgine
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
PRECURSORII CANCERULUI
SCUAMO-CELULAR
Carcinom in situ
Displazii (CIN1-3):
displazie usoara
displazie moderata
displazie severa
Aspectul macroscopic testul Schiller
- pozitiv negativ
- nu toate testele Schiller negative ~ leziune maligna
Aspect microscopic diagnostul histologic este instrumentul de diagnostic
definitiv = modificari nucleare (pleiomorfism nuclear, hipercromatism,
multinucleism, mitoze)
CIN = jonctiune scuamo-columnara
Invazia de la locul de origine
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
TESTUL BABES-PAPANICOLAU
___________________________________
___________________________________
Semnificatie
Caracteristici citologice
Rata fals negativa 10-35%
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
ROLUL HPV
Peste 60 de subtipuri
Mai patogene: 16, 18, 31, 45, 56
Leziuni HPV:
HPV vulva
perineu
anus
col
vagin
Detectie
- microscopie electronica
- imunohistochimie
- tehnici de hibridizare
- PCR
Rol biopsie cervicala conizatie electrica
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
CARCINOM INVAZIV
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Grade histologice
ASPECT MACROSCOPIC AL
CC SCUAMO-CELULAR
Tumori
Extinderea tumorii
- vagin
- ligamentele cardinale
- endometriala - rara
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
DIAGNOSTIC
___________________________________
___________________________________
Sangerari
vaginale neregulate
in afara ciclului menstrual
post-coitale
intermenstruale
postmenopauzale
___________________________________
___________________________________
___________________________________
___________________________________
10
___________________________________
CLASIFICAREA FIGO
Stadiul 0 carcinom in situ, carcinom intraepitelial
Stadiul I neoplasme ce nu depadsesc colul
IA invazie stromala sub 3mm grosime si sub 7mm latime
IB prezinta
IB1 diametrul maxim sub 4cm
IB2 diametrul maxim mai mare decat 4cm
Stadiul II
IIA extensia spre cele 2/3 superioare ale vaginului
IIB infiltrarea tesuturilor parametriale
Stadiul III
IIIA implicarea 1/3 anterioare vaginale
IIIB infiltrarea peretilor parametriali (prin tuseu rectal)
Stadiul IV
IVA invazia vezicii sau a rectului
IVB metastaze la distanta
11
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Frecventa metastazelor
___________________________________
___________________________________
Stadiul I 15%
Stadiul II 30%
___________________________________
___________________________________
___________________________________
___________________________________
12
___________________________________
TRATAMENT
Faza preinvaziva:
preinvaziva
chiuretaj endocervical negativ
chiuretaj endocervical pozitiv = conizatie
formele incipiente de CIN: biopsie sau DCC
CC in situ
~ dorinta pacientei vis--vis de reproducere
~ stadiul cervical
chirurgia preferata radioterapiei
criochirurgia
laser terapia cu CO2
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
13
___________________________________
TRATAMENT
Faza invaziva:
invaziva
stadializarea clinica limitele bolii
chirurgia si radioterapia = principale metode de tratament
informarea pacientei
chirurgia radicala
invadarea ggl paraaortici radioterapie complicatiile
chimioterapia si imunoterapia
exenteratia pelvina
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
14
___________________________________
PROGNOSTICUL BOLII
90% din recurente apar in primii 2 ani (nodulii paraaortici, ficat, plamani)
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
15
___________________________________
CC IN SARCINA
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________